Sanin A.V., Kozhevnikova T. N., Agafonova A.D., Annikov V. V., Annikova L. V.,

* N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology of the Ministry of Health of Russian Federation,
(18, Gamaleya Str., Moscow, 123098, Russia) tel: 8 (499) 190-58-51

** N. A. Vavilov Saratov State Agrarian University., tel: 8(845) 2 - 69-25-32

The aim of this work was to investigate the therapeutic efficacy of gamavit as a detoxicant, hemostimulant and immunomodulator in the treatment of babesiosis in dogs. The study included 150 dogs with confirmed diagnosis of babesiosis aged from 1 year to 5 years. All animals were divided into 2 equal groups. Animals of the control group were treated with imidosan, and symptomatic drugs - essentiale forte, 0.9% sodium chloride solution or 5% glucose, intravenous 5% ascorbic acid, enrofloxacin 5%. Dogs of the experimental group were additionally inoculated with gamavit 0.5 ml per 1 kg of body weight 2 times a day intravenously. It is shown that the inclusion of gamavit in the therapy of babesiosis leads to fast relief of anemia, recovery of blood counts, decrease in inflammatory response, normalization of liver function and accelerates the clinical recovery of the dogs.

Keywords: dogs, babesiosis, gamavit, detoxicant, anemia, hematopoiesis, blood count, C-reactive protein

Veterinary journal of Belarus 1(6)/2017